Cart
sales@molnova.com
Jujuboside B
CAS No. 55466-05-2
Jujuboside B( —— )
Catalog No. M18803 CAS No. 55466-05-2
Jujuboside B has potent inhibitory effects on collagen-, thrombin-, AA-, and ADP-induced aggregation, and also exhibits superior protection on the thromboembolic model.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 75 | In Stock |
|
| 10MG | 130 | In Stock |
|
| 25MG | 254 | In Stock |
|
| 50MG | 370 | In Stock |
|
| 100MG | 542 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1144 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJujuboside B
-
NoteResearch use only, not for human use.
-
Brief DescriptionJujuboside B has potent inhibitory effects on collagen-, thrombin-, AA-, and ADP-induced aggregation, and also exhibits superior protection on the thromboembolic model.
-
DescriptionJujuboside B has potent inhibitory effects on collagen-, thrombin-, AA-, and ADP-induced aggregation, and also exhibits superior protection on the thromboembolic model.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number55466-05-2
-
Formula Weight1045.21
-
Molecular FormulaC52H84O21
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (95.67 mM)
-
SMILES[C@@H]1([C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@H]1[C@@H](OC[C@@H]([C@@H]1O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@H]1[C@@H]([C@H]([C@@H](CO1)O)O)O)O)O[C@@H]1C([C@@H]2CC[C@]3([C@]45C[C@@]6(O[C@H](C[C@]([C@@H]6C4CC[C@@H]3[C@]2(CC1)C)(C)O)C=C(C)C)OC5)C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Seo EJ,et al. Zizyphus jujuba and its active component jujuboside B inhibit platelet aggregation. Phytother Res. 2013 Jun;27(6):829-34.
molnova catalog
related products
-
DpC
DPC is an antitumor compound that inhibits cancer cell proliferation with an IC50 of 0.007-0.096 μM.DPC is involved in a variety of anticancer therapies and can be used in cancer research.
-
Hinesol
(-)-Hinesol (Hinesol) is a potent anticancer agent. (-)-Hinesol induces apoptosis and cell cycle arrest at G0/G1 phase. (-)-Hinesol downregulates MEK/ERK pathway and NF-κB pathway and mediates theexpression of cyclin D1, Bax and Bcl-2. (-)-Hinesol has the potential for the research of non–small cell lung cancer.
-
TNG908
TNG908 is an orally active and selective MTAP-co-PRMT5 inhibitor that crosses the blood-brain barrier and kills MTAP-deficient cancers.
